This website is intended for healthcare professionals

Chronic kidney disease

Audit and re-audit of medication use in patients with impaired kidney function

To identify medications that were most likely to be prescribed at inappropriate doses in patients with CKD 3-5, and to implement methods to improve patient care in this area by sharing results with...

Evidence-based use of newer agents in type 2 diabetes

Recent accumulating evidence on the use of newer therapies in type 2 diabetes (T2DM) is helping to define their position in treatment. This information coupled with the increasing priority given...

Prescribing in patients with kidney disease

Diabetes accounts for nearly half of CKD diagnoses in the UK and over 10 000 people have end-stage kidney disease as a result of their diabetes (UK Renal Registry, 2018). An ageing population, coupled...

Preventing complications and managing symptoms of CKD

CKD is used as a general term used when someone has signs of abnormal kidney function – either a reduction in estimated glomerular filtration rate (eGFR) to less than 60 ml/min/1.73 m2 or an increase...

Why choose Journal of Prescribing Practice?

Journal of Prescribing Practice shares the latest clinical expertise and professional guidance for non-medical prescribers. Our goal is to provide the knowledge to help you prescribe more efficiently and effectively.

What's included

  • Evidence-based best practice

  • Drug updates

  • Pharmacology information

  • Calculation skills

Subscriptions start:

From £16.25 GBP